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Abstract
Background—Dried blood spots (DBS) are collected universally from newborns and may be 
valuable for the diagnosis of congenital Cytomegalovirus (CMV) infection. The reported 
analytical sensitivity for DBS testing compared to urine or saliva varies greatly across CMV 
studies. The purpose of this study was to directly compare the performance of various DNA 
extraction methods for identification of CMV in DBS including those used most often in CMV 
studies.
Study design—Whatman® Grade 903 filter paper cards were spotted with blood samples from 
25 organ transplant recipients who had confirmed CMV viremia. Six DNA extraction methods 
were compared for relative yield of viral and cellular DNA: 2 manual solution-based methods 
(Gentra Puregene, thermal shock), 2 manual silica column-based methods (QIAamp DNA Mini, 
QIAamp DNA Investigator), and 2 automated methods (M48 MagAttract Mini, QIAcube 
Investigator). DBS extractions were performed in triplicate followed by real-time quantitative 
PCR (qPCR).
Results—For extraction of both viral and cellular DNA, two methods (QIAamp DNA 
Investigator and thermal shock) consistently gave the highest yields, and two methods (M48 
MagAttract Mini and QIAamp DNA Mini) consistently gave the lowest yields. There was an 
average 3-fold difference in DNA yield between the highest and lowest yield methods.
Conclusion—The choice of DNA extraction method is a major factor in the ability to detect low 
levels of CMV in DBS and can largely account for the wide range of DBS sensitivities reported in 
studies to date.
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1. Background
Human Cytomegalovirus (CMV) is a leading cause of congenital infections worldwide. The 
frequency of congenital CMV infection varies in different populations but on average is 
approximately 0.7% of live births, with 15–20% of infected children developing permanent 
disability including hearing loss, vision loss, and cognitive impairment [1–3]. The most 
common of these disabilities is hearing loss for which congenital CMV infection is a major 
cause in young children second only to genetic mutations [4].
US newborns are currently screened within the first week of life for a wide range of birth 
defects through the collection of blood on filter paper in the form of dried blood spots 
(DBS). DBS have been shown to provide >95% sensitivity compared to urine or saliva for 
the retrospective diagnosis of congenital Cytomegalovirus infection in children born with 
CMV-associated symptoms or born to mothers who had primary CMV infection during 
pregnancy [5,6]. In contrast, in studies where CMV screening was performed on unselected 
newborn populations the reported sensitivity of DBS relative to urine or saliva has varied 
widely from 28 to 80% [7–9]. Because of numerous differences between studies, it was 
difficult to ascertain the reason for the wide range in results. To establish that lab methods 
are an important variable in DBS testing sensitivity, de Vries and others compared available 
DNA extraction methods for DBS and showed large differences in performance among the 
methods [10].
2. Objectives
The aim of our study was to extend previous method comparisons and include the two DNA 
extraction methods most frequently used in CMV studies (QIAamp DNA Mini and thermal 
shock) [6,8,11–14] and the automated method used by the largest CMV newborn screening 
study to date (M48 MagAttract Mini) [9]. The goal was to contribute additional important 
information relevant to the ongoing debate over the potential utility of DBS for CMV testing 
in newborns.
3. Study design
3.1. Blood samples and dried blood spots
De-identified CMV DNA positive EDTA whole blood from 25 organ transplant recipients 
was kindly provided by The Cleveland Clinic Foundation, Dept. of Clinical Pathology, 
Cleveland, OH. Blood specimens had CMV viral loads ranging from a low of 7 × 102 
copies/ml to a very high 1 × 106 copies/ml. Replica blood spots were prepared by dispensing 
75 μl of blood onto the circles of Whatman® 903 Specimen Collection Paper. After drying 
the spots overnight, punches were prepared manually for DNA extraction methods with 
negative control punches between each sample. Remaining DBS material was stored at −20 
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°C with desiccant. CMV DNA-negative EDTA whole blood from healthy volunteers was 
spotted and used as negative controls.
3.2. Extraction of DNA from DBS
DNA was extracted from DBS using the following six extraction methods: (1) QIAamp 
DNA Investigator kit, (2) QIAamp DNA Investigator kit with QIAcube automation, (3) 
QIAamp DNA Mini kit, (4) MagAttract DNA Mini kit with BioRobot M48 automation, (5) 
thermal shock, and (6) Gentra Puregene. Sample input for all methods was 3 punches of 3.2 
mm in size with the exception of the thermal shock method which used one 6 mm punch. 
Input volume of whole blood was calculated based on the area of the blood spots extracted. 
Samples were extracted in triplicate for each method. With the exception of thermal shock, 
all extraction methods were kit-based (Qiagen, Valencia, CA) and DNA extracted following 
the manufacture’s protocols for isolation of total DNA from DBS. Carrier RNA was added 
to Buffer AL as recommended for small amounts of DNA. DNA extracted using thermal 
shock followed the method developed by Shibata and modified by Barbi [14,15]. Briefly, 
one 6-mm punch was soaked in 60 μl minimum essential medium (MEM) at room 
temperature for 2 h with shaking (300 rpm) followed by incubation at 56 °C for 1 h, and 
incubation at 100 °C for 7 min. Samples were placed on ice for at least 2 min, spun in a 
centrifuge at 14,000 rpm for 5 min, and stored at −80 °C overnight. Prior to PCR testing, 
samples were thawed and transferred to a DNA IQ Spin Basket (Promega) inserted into an 
elution tube, centrifuged at 14,000 rpm for 3 min and the liquid flow through used directly 
for qPCR.
3.3. Real-time PCR
Viral DNA was amplified using primers and probes that target the conserved envelope 
glycoprotein B as described [9] with addition of TaqMan Universal PCR master mix and an 
exogenous internal positive control (Applied Biosystems, Foster City, CA). PCR testing was 
performed in triplicate for all samples. AD169 (Advanced Biotechnologies) was used as 
quantitation standard. PCR cycling on the ABI 7900HT (Applied Biosystems) was as 
follows: 95 °C, 10 min.; 95 °C, 15 s., 60 °C, 1 min for 45 cycles; 4 °C hold. Genomic DNA 
was quantified using the same reaction conditions. The following primers and probe that 
target the cellular RNaseP gene were used: forward primer: 5′-
AGATTTGGACCTGCGAGCG-3′; reverse primer: 5′-GAGCGGCTGCTCCACAAGT; 
probe: FAM-5′-TTCTGACCTGAAGGCTCTGCGCG-3′.
3.4. Data analysis
For quantitative results, negative samples were included as zero when calculating mean viral 
loads. CMV quantitation results were used to classify specimens into three viral load 
categories: low (<10 copies/μl spotted blood), intermediate (~10–100 copies/μl spotted 
blood), and high (>100 copies/μl spotted blood). For qualitative results, DBS samples were 
counted positive when two or more of the triplicate PCR reactions tested positive.
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Fig. 1 shows the DNA yields for six extraction methods used on DBS made with low CMV 
viral load blood (left panel, n = 8) and intermediate CMV viral load blood (right panel, n = 
11). For low viral load specimens, manual extraction with Investigator and thermal shock 
produced the highest DNA yields; Qiagen Mini and M48 MagAttract gave the lowest yields. 
There was a 3-fold difference in mean DNA yield between the two highest and two lowest 
yield extraction methods (p < 0.0001, student’s t-test). For intermediate viral load 
specimens, manual Investigator and QIAcube Investigator produced the highest CMV DNA 
yields; Qiagen Mini and M48 MagAtract gave the lowest CMV DNA yields representing a 
3-fold difference between the mean DNA yields for the two highest and two lowest yield 
extraction methods (p < 0.0006, student’s t-test). For high viral load specimens, differences 
between methods were not significant.
Mean CMV DNA yields expressed as log10 for the low or intermediate viral load categories 
are displayed together in Fig. 2. For the low viral load category samples, the manual 
Investigator and thermal shock methods gave yields of CMV DNA significantly greater than 
those obtained from the Qiagen Mini (p ≤ 0.05, student’s t-test) or the M48 MagAttract (p ≤ 
0.05, Student’s t-test). For the intermediate viral load category samples, all methods gave 
yields of CMV DNA significantly greater than those obtained from the M48 MagAttract (p 
≤ 0.05, student’s t-test). Moreover, the manual Investigator and QIAcube Investigator 
methods gave yields of CMV DNA significantly greater than those obtained from the 
Qiagen Mini kit (p ≤ 0.05, student’s t-test).
For extraction of genomic DNA, relative performance of the various extraction methods was 
similar to that seen for viral DNA. Fig. 3 shows the results of qPCR for RNAseP performed 
on the same DNA extracts as that used for CMV qPCR. Investigator and thermal shock 
produced the highest DNA yields; Qiagen Mini and M48 MagAt-tract gave the lowest 
yields. There was a 3-fold difference in DNA yield between the two highest and the two 
lowest yield extraction methods.
4.2. Qualitative results
In addition to measuring DNA yields among extraction methods, we compared CMV 
positive and negative results for each method. Table 1 lists the percent of samples in each 
viral load category that was identified as positive for each extraction method. For specimens 
with low viral load, CMV DNA detection ranged from 100% to 46% of samples. The top 
two methods for detection of CMV in DBS were thermal shock (100%) and manual 
Investigator (88%). The lowest detection rates were seen with M48 MagAttract and Qiagen 
Mini (58% and 46%, respectively), with these differences being significant (p < 0.01, 
student’s t-test).
For DBS specimens in the intermediate viral load category, CMV detection rates were 
higher with 3 methods showing 100% CMV detection and the lowest method showing 85% 
detection (Table 1), with this difference being significant (p < 0.05, student’s t-test). When 
testing DBS with high CMV loads, all extraction methods identified 100% of DBS 
Koontz et al. Page 4













specimens as positive. All CMV DNA negative control samples tested negative, and there 
was no PCR inhibition seen with any of the extraction methods.
5. Discussion
Our study found large and consistent differences in the relative performance of six DNA 
extraction methods for DBS measuring yields for both genomic and viral DNA at multiple 
concentrations. The highest yield methods were Investigator manual and thermal shock; the 
lowest yield methods were Qiagen mini and M48 MagAttract. Two of the above mentioned 
methods, thermal shock [14–18] and Qiagen mini [6,9,11–13], have been used by several 
CMV studies and showed variable sensitivities for identifying CMV infection in children. 
But the studies varied widely, mainly regarding the sample size and the extent to which it 
was enriched for infants with symptomatic CMV infection. The largest CMV newborn 
screening study to date was the CMV and Hearing Multicenter Screening (CHIMES) study 
that used the M48 MagAttract method for DBS testing. DBS sensitivity observed in 
CHIMES was the lowest reported to date at 28–34% compared to saliva and it was 
concluded that DBS would not be suitable for newborn screening [9]. However, our study 
showed that M48 MagAttract had the lowest DNA yield of the 6 methods evaluated which 
was likely a contributing factor to the poor performance of DBS testing in CHIMES [9].
A major strength of the present study is the comprehensive expertise at CDC for DBS 
diagnostic testing. The Newborn Screening and Molecular Biology Branch at CDC 
manufacturers and validates quality assurance materials for all biomarkers associated with 
the core conditions on the Recommended Uniform Screening Panel. A second strength of 
the study was the use of blood from patients with CMV viremia, as opposed to the often 
used CMV uninfected blood spiked with laboratory strain AD169. The results of our study 
were consistent with those from the DBS method comparison by de Vries [10], which 
examined seven different extraction methods (four of which are in common with our study) 
and also used blood from patients with CMV viremia. Concordant with our study, the 
Investigator manual and thermal shock methods showed superior performance for detection 
of CMV. A third DBS methods comparison by Gohring [19] included four methods and 
showed the Qiagen Mini kit performed much better than thermal shock (referred to as heat). 
However the Gohring study used AD169-spiked blood instead of naturally infected blood, 
and their thermal shock (heat) method did not include the important pre-incubation of DBS 
at either 4 °C overnight [10] or at room temperature for 2 h.
Methods that are under consideration for newborn screening need to be sensitive, adaptable 
to automation, and cost-effective. Extraction methods used in our study that provided the 
best results for CMV detection from DBS (Investigator manual and thermal shock) are low 
throughput and thus in their current form are not suitable for newborn screening. However 
with sufficient market demand, these methods could potentially be developed for higher 
throughput and lower cost. The thermal shock protocol has the advantage of very low cost 
over the other methods tested but does have the disadvantage of an overnight freezing step. 
This will be addressed in future work.
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For CMV newborn screening, it is clear DBS would offer lower analytical sensitivity than 
saliva or urine. However, only 15–20% of children with congenital CMV infection develop 
permanent disabilities [2,3] and they are largely the children born with higher viral loads 
[20–22] Thus, DBS-based detection may offer adequate clinical sensitivity. Moreover, 
amplification methodologies continue to improve and provide increased sensitivity. 
Atkinson recently reported enhanced detection of CMV from DBS using a single tube nested 
PCR [23]. In conclusion, our study demonstrates that DBS warrant further consideration for 
identification of newborns at risk for disability from congenital CMV infection.
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Quantitative results for CMV DNA yield according to extraction method. Data points 
(circles) represent the average CMV DNA yield for each DBS specimen from triplicate 
extractions. Vertical lines show the full range of DNA yield per method. Mean (square) and 
median (diamond) viral DNA yields for the complete sample set are shown for each 
extraction method, with numeric values for means shown.
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Overall quantitative results for CMV DNA yield from six extraction methods. Average 
DNA yields for all specimens combined is shown for each extraction method, for low and 
intermediate viral load categories.
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Quantitative results for extraction of total genomic DNA: the mean genomic DNA yield 
measured by qPCR targeting housekeeping gene RNAse P. Replica extractions quantified in 
duplicate were performed for all 25 blood samples.
Koontz et al. Page 10

























Koontz et al. Page 11
Table 1
Qualitative assessment. Percentage of CMV-positive DBS in which CMV was detected following various 
extractions methods.
Method Low viral load category (n = 8) (%) Intermediate viral load category (n = 11) (%)
Investigator – manual 88 97
Investigator – QIAcube 79 100
Qiagen mini 46 91
Thermal shock 100 100
Gentra puregene 67 100
M48 MagAttract 58 85
J Clin Virol. Author manuscript; available in PMC 2015 July 28.
